174 related articles for article (PubMed ID: 20209877)
21. Glucocorticoids and the regulation of memory in health and disease.
de Quervain DJ; Aerni A; Schelling G; Roozendaal B
Front Neuroendocrinol; 2009 Aug; 30(3):358-70. PubMed ID: 19341764
[TBL] [Abstract][Full Text] [Related]
22. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala.
Yang YL; Lu KT
Neuroscience; 2005; 134(1):247-60. PubMed ID: 15951121
[TBL] [Abstract][Full Text] [Related]
23. [A novel therapeutic approach for the treatment of post-traumatic stress disorder (PTSD): enhancing the impaired extinction of fear memory].
Yamamoto S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):135-9. PubMed ID: 19663264
[TBL] [Abstract][Full Text] [Related]
24. The effect of D-cycloserine on immediate vs. delayed extinction of learned fear.
Langton JM; Richardson R
Learn Mem; 2010 Nov; 17(11):547-51. PubMed ID: 20971937
[TBL] [Abstract][Full Text] [Related]
25. Fear extinction in rats: implications for human brain imaging and anxiety disorders.
Milad MR; Rauch SL; Pitman RK; Quirk GJ
Biol Psychol; 2006 Jul; 73(1):61-71. PubMed ID: 16476517
[TBL] [Abstract][Full Text] [Related]
26. Effects of D-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels.
Wu SL; Hsu LS; Tu WT; Wang WF; Huang YT; Pawlak CR; Ho YJ
Behav Brain Res; 2008 Mar; 187(2):246-53. PubMed ID: 17959260
[TBL] [Abstract][Full Text] [Related]
27. Corticosterone facilitates extinction of fear memory in BALB/c mice but strengthens cue related fear in C57BL/6 mice.
Brinks V; de Kloet ER; Oitzl MS
Exp Neurol; 2009 Apr; 216(2):375-82. PubMed ID: 19162011
[TBL] [Abstract][Full Text] [Related]
28. Effects of D-cycloserine on extinction of learned fear to an olfactory cue.
Weber M; Hart J; Richardson R
Neurobiol Learn Mem; 2007 May; 87(4):476-82. PubMed ID: 17275356
[TBL] [Abstract][Full Text] [Related]
29. D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement.
Ledgerwood L; Richardson R; Cranney J
Behav Neurosci; 2004 Jun; 118(3):505-13. PubMed ID: 15174928
[TBL] [Abstract][Full Text] [Related]
30. Posttraumatic stress disorder: a state-of-the-science review.
Nemeroff CB; Bremner JD; Foa EB; Mayberg HS; North CS; Stein MB
J Psychiatr Res; 2006 Feb; 40(1):1-21. PubMed ID: 16242154
[TBL] [Abstract][Full Text] [Related]
31. D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response.
Woods AM; Bouton ME
Behav Neurosci; 2006 Oct; 120(5):1159-62. PubMed ID: 17014266
[TBL] [Abstract][Full Text] [Related]
32. The Melatonergic System in Anxiety Disorders and the Role of Melatonin in Conditional Fear.
Huang F; Yang Z; Li CQ
Vitam Horm; 2017; 103():281-294. PubMed ID: 28061973
[TBL] [Abstract][Full Text] [Related]
33. Memory modification as an outcome variable in anxiety disorder treatment.
Tryon WW; McKay D
J Anxiety Disord; 2009 May; 23(4):546-56. PubMed ID: 19117720
[TBL] [Abstract][Full Text] [Related]
34. mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity.
Fendt M; Schmid S; Thakker DR; Jacobson LH; Yamamoto R; Mitsukawa K; Maier R; Natt F; Hüsken D; Kelly PH; McAllister KH; Hoyer D; van der Putten H; Cryan JF; Flor PJ
Mol Psychiatry; 2008 Oct; 13(10):970-9. PubMed ID: 17712315
[TBL] [Abstract][Full Text] [Related]
35. d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference.
Botreau F; Paolone G; Stewart J
Behav Brain Res; 2006 Sep; 172(1):173-8. PubMed ID: 16769132
[TBL] [Abstract][Full Text] [Related]
36. In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disorders.
Kilts C
Psychopharmacol Bull; 2003; 37 Suppl 1():19-28. PubMed ID: 14566198
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of reconsolidation and extinction of fear memory].
Kida S; Fukushima H; Mamiya N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):125-33. PubMed ID: 19663263
[TBL] [Abstract][Full Text] [Related]
38. D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms.
Grillon C
Biol Psychiatry; 2009 Oct; 66(7):636-41. PubMed ID: 19520359
[TBL] [Abstract][Full Text] [Related]
39. Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: initial validation of an imaging protocol for drug discovery.
Giménez M; Ortiz H; Soriano-Mas C; López-Solà M; Farré M; Deus J; Martín-Santos R; Fernandes S; Fina P; Bani M; Zancan S; Pujol J; Merlo-Pich E
Eur Neuropsychopharmacol; 2014 Jan; 24(1):105-16. PubMed ID: 24332890
[TBL] [Abstract][Full Text] [Related]
40. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
